alexa
Reach Us 447460731551
Anthony M. Szema | OMICS International
ISSN: 2329-6879

Occupational Medicine & Health Affairs
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
  • 12th Edition of International Conference on Preventive Medicine & Public Health
    March 05-06, 2020 Rome, Italy
  • 2nd Annual Congress on Medicine
    March 23-24, 2020 Yokohama, Japan
  • 3rd International conference on Emergency & Acute Care Medicine
    September 24-25, 2020 Singapore City, Singapore

Anthony M. Szema

Anthony M. Szema Assistant Professor
Medicine and Surgery
Stony Brook University School of Medicine
USA

Biography

Anthony M. Szema is an assistant professor of medicine and surgery, Stony Brook School of Medicine and is Chief, Allergy Section, Veterans Affairs Medical Center, Northport, NY. His undergraduate degree in Industrial and Management Engineering is from Rensselaer Polytechnic Institute, Troy, NY. He took his MD at Albany Medical College, Albany, NY, where he was Vice-President of his class during 3rd and 4th years. As VP, he coordinated the first student-run evaluations of third-year clerkships in the history of the college. Dr. Szema completed his internship in medicine at Hopkins, residency at Hahnemann, and three fellowships at Columbia in: Pulmonary Diseases, Critical Care Medicine, and Clinical Adult and Pediatric Allergy and Immunology. He is Principal Investigator of NIH K08 HL07623 under the aegis of mentor Sami I. Said, MD, Distinguished SUNY Professor. They have reported a spontaneous asthma model in mice missing the gene for Vasoactive Intestinal Peptide (VIP). Dr. Szema is conducting an open label trial of recombinant C1 esterase inhibitor for patients with attacks of Hereditary Angioedema (HAE) sponsored by Pharming, NV. Working with medical students, Dr. Szema coordinates a long-term study of asthmatic children affected by the World Trade Center disaster.

Research Interest

Pulmonary Diseases, Critical Care Medicine, and Clinical Adult and Pediatric Allergy and Immunology

Relevant Topics
Top